Premenstrual Syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: The stress management’ group received four sessions of group consultation on stress management. Intervention 2: Vitamin B6 group received 80 mg Vitamin B6 pill daily for two menstrual
Treatment - Drugs
The stress management’ group received four sessions of group consultation on stress management.
Vitamin B6 group received 80 mg Vitamin B6 pill daily for two menstrual cycles, one week before their menstruation get started
No interference seen in the Control group
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: written informed consent; suffering from moderate to acute premenstrual syndrome; having regular periods within 21-35 days intervals with 2-7 days of bleeding; obtaining a score lower than 23 in general health questionnaire; lack of known physical or psychiatric diseases according to the general health questionnaire; failure to use premenstrual syndrome treatment procedures in order to alleviate its symptoms; absence of stressful occasions such as parents’ divorce- severe financial failure- accident- death of a close relative- any surgical operations 3 months before the onset of this study; being at least 18 years old- lack of treatment of endocrine and metabolic disorders, epilepsy or any menstrual disorder from 3 months before the onset of this study; not following a special diet. Exclusion criteria: A terrible accident like intense family disputes- separation from parents- severe financial problems- death of a close relative during research period; being absent more than once from consultation sessions; establishment of side-effects during use of medication and being forced to withdraw it; leaving the study for any reason.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mood symptoms of premenstrual syndrome. Timepoint: Before and two months after intervention. Method of measurement: questionnaire.;Physical symptoms of premenstrual syndrome. Timepoint: Before and two months after intervention. Method of measurement: questionnaire.;Behavioral symptoms of premenstrual syndrome. Timepoint: Before and two months after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed